Literature DB >> 9208538

[Effect of concentrated xuefu zhuyu pill on proliferation of vascular smooth muscle cells in experimental atheriosclerosis rabbits observed by serologic pharmacological test].

Q H Zhang1, B Zhong, K J Chen.   

Abstract

Two in vitro experiments were performed for comparative study to evaluate the effect of concentrated Xuefu Zhuyu pill (CXZP), a Chinese traditional herbal medicinal mixture, on the proliferation of vascular smooth muscle cells (SMCs) of experimental atherosclerosis rabbits by serologic pharmacological test. The first experiment approach adopted the addition of the rabbit's serum to the culture medium while in the second experiment the CXZP was added to the medium directly. Results showed that both the serum with CXZP and the CXZP extract itself could inhibit the proliferation of SMC significantly and dose-dependently, and the inhibitory action of the latter was more potent than the former one. It suggested that CXZP could inhibit the proliferation of SMC both in vivo and in vitro, the decrease of effectiveness in vivo might be due to the non-absorption of some active ingredient of CXZP or due to metabolic inactivation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9208538

Source DB:  PubMed          Journal:  Zhongguo Zhong Xi Yi Jie He Za Zhi        ISSN: 1003-5370


  3 in total

1.  Effect of anti-fibrosis compound on collagen expression of hepatic cells in experimental liver fibrosis of rats.

Authors:  Ling-Tai Wang; Bin Zhang; Jian-Jie Chen
Journal:  World J Gastroenterol       Date:  2000-12       Impact factor: 5.742

2.  Effects of pharmacological serum from normal and liver fibrotic rats on HSCs.

Authors:  Xi-Xian Yao; Tao Lv
Journal:  World J Gastroenterol       Date:  2005-04-28       Impact factor: 5.742

3.  Comparison of protocatechuic aldchyde in Radix Salvia miltiorrhiza and corresponding pharmacological sera from normal and fibrotic rats by high performance liquid chromatography.

Authors:  Tao Lv; Xi-Xian Yao
Journal:  World J Gastroenterol       Date:  2006-04-14       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.